|
Fluoride Action Network October 11, 2001
Study Finds Link between High Fluoride & Kidney Stones
A new study (see below) published in the journal Urological
Research, has found an association between high levels of fluoride
in the water and painful kidney stones. According to the study,
urolithiasis (kidney stones) was 4.6 times more common in an area
with high fluoride (3.5 to 4.9 ppm) than in a similar area without
high fluoride. Moreover, in the high fluoride area, the prevalence
of kidney stones "was almost double in subjects with fluorosis
than without fluorosis."
A kidney stone, according to Yahoo
Health:
"results when the urine becomes too concentrated and substances
in the urine crystallize to form stones. Stones may not produce
symptoms until they begin to move down the ureter, causing pain.
The pain is severe, located in the flank, and often described
as 'the worst pain ever experienced.'
Kidney stones are common. About 5% of women and 10% of men will
have at least one episode by age 70. Kidney stones affect about
2 out of every 1,000 people. Recurrence is common, and the risk
of recurrence is greater if two or more episodes of kidney stones
occur. Kidney stones are common in premature infants."
According to Focus
On Womens' Health:
"The pain with kidney stones is usually of sudden onset,
very severe and colicky (intermittent), not improved by changes
in position, radiating from the back, down the flank, and into
the groin. Nausea and vomiting are common...
The process of stone formation, urolithiasis, is also called
nephrolithiasis. "Nephrolithiasis" is derived
from the Greek nephros- (kidney) lithos (stone) = kidney stone
"Urolithiasis" is from the French word "urine"
which, in turn, stems from the Latin "urina" and the
Greek "ouron" meaning urine = urine stone. The stones
themselves are also called renal caluli. The word "calculus"
(plural: calculi) is the Latin word for pebble."
Urological Research 2001 Aug; 29(4):238-44
Evidence suggesting that high intake of fluoride provokes nephrolithiasis
in tribal populations.
Singh PP, Barjatiya MK, Dhing S, Bhatnagar R, Kothari S, Dhar
V.
Department of Biochemistry, Darshan Dental College, Madhuvan, India.
siraj_52ali@usa.net
The present study was designed to evaluate the role of fluoride
in urolithiasis in humans. Two areas were selected for this purpose,
a fluoride endemic area (EA) and a fluoride non-endemic area (NEA).
The prevalence of urolithiasis was 4.6 times higher in EA than
in NEA. Furthermore, the prevalence was almost double in subjects
with fluorosis than without fluorosis in the endemic area. No
relationship was observed between urolithiasis and the duration
of fluorosis. The fluoride levels in drinking water ranged from
3.5 to 4.9 ppm in EA and subjects from this area excreted more fluoride.
A comparison of normal subjects (NS) from EA and NEA revealed that
endemic subjects tend to have slightly higher mean serum thiobarbituric
acid reactive substance (TBAR) levels and excrete more oxalate and
fluoride than their non-endemic counterparts. The urinary stone
formers (SF) from the two areas showed a similar tendency, though
again the difference was not significant. Citrate excretion in SF
was almost normal in the EA, but NEA SF had significantly lower
excretion levels. Urinary stones from endemic patients had higher
fluoride, oxalate and calcium levels than those from non-endemic
patients. In vitro studies suggested that fluoride did not influence
the heterogonous mineralization of calcium oxalate. In conclusion,
the data suggest that fluoride in vivo may behave as a mild promoter
of urinary stone formation by (a) excretion of insoluble calcium
fluoride, (b) increasing oxalate excretion and (c) mildly increasing
the oxidative burden.
http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=
PubMed&list_uids=11585278&dopt=Abstract
PMID: 11585278 [PubMed - in process] |